US Patent Issued to Alyssum Therapeutic s on July 15 for "B-cell immunotherapy in cancer treatment" (American, Indian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,699, issued on July 15, was assigned to Alyssum Therapeutic s Inc. (Cambridge, Mass.).

"B-cell immunotherapy in cancer treatment" was invented by Shiladitya Sengupta (Waltham, Mass.) and Aniruddha Sengupta (Delhi, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods for treating cancer in a patient, comprising administering to the patient (i) a therapeutically effective amount of a compound of formula (VIII), or a pharmaceutically acceptable salt thereof, wherein Q, linker, and lipid are defined herein, and (ii) a therapeutically effective amount of an immune checkpoint inhibitor. Q-linker-lipid (VIII) In some...